Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration.
Proc Natl Acad Sci U S A. 2021 Oct 12;118(41):e2102975118. doi: 10.1073/pnas.2102975118.
Proc Natl Acad Sci U S A. 2021.
PMID: 34620711
Free PMC article.